ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Based Preclinical CRO Market Research Report 2026
Published Date: 2026-02-26
|
Report Code: QYRE-Auto-39H8946
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncology Based Preclinical CRO Market Size Status and Forecast 2022
BUY CHAPTERS

Global Oncology Based Preclinical CRO Market Research Report 2026

Code: QYRE-Auto-39H8946
Report
2026-02-26
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
Evotec AG
The Jackson Laboratory
MI Bioresearch
Champion Oncology
WuXi AppTec
Xentech
Living Tumor Laboratory

Oncology Based Preclinical CRO Market Size

The global Oncology Based Preclinical CRO market was valued at US$ 533 million in 2025 and is anticipated to reach US$ 1195 million by 2032, at a CAGR of 12.4% from 2026 to 2032.

Oncology Based Preclinical CRO Market

Oncology Based Preclinical CRO Market

Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
The industry"s leading producers are Crown Bioscience, Charles River and ICON, with revenues of 18.32 percent, 13.86 percent and 9.13 percent in 2019.
This report delivers a comprehensive overview of the global Oncology Based Preclinical CRO market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oncology Based Preclinical CRO. The Oncology Based Preclinical CRO market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Oncology Based Preclinical CRO market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Oncology Based Preclinical CRO manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Oncology Based Preclinical CRO Market Report

Report Metric Details
Report Name Oncology Based Preclinical CRO Market
Accounted market size in 2025 US$ 533 million
Forecasted market size in 2032 US$ 1195 million
CAGR 12.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Blood Cancer
  • Solid Tumors
  • Others
Segment by Application
  • In Vitro
  • In Vivo
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Crown Bioscience, Charles River, ICON, Eurofins Scientific, Taconic Biosciences, Covance, EVOTEC, The Jackson Laboratory, MI Bioresearch, Champion Oncology, Wuxi AppTec., Xentech, Living Tumor Laboratory
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Oncology Based Preclinical CRO companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Oncology Based Preclinical CRO Market growing?

Ans: The Oncology Based Preclinical CRO Market witnessing a CAGR of 12.4% during the forecast period 2026-2032.

What is the Oncology Based Preclinical CRO Market size in 2032?

Ans: The Oncology Based Preclinical CRO Market size in 2032 will be US$ 1195 million.

Who are the main players in the Oncology Based Preclinical CRO Market report?

Ans: The main players in the Oncology Based Preclinical CRO Market are Crown Bioscience, Charles River, ICON, Eurofins Scientific, Taconic Biosciences, Covance, EVOTEC, The Jackson Laboratory, MI Bioresearch, Champion Oncology, Wuxi AppTec., Xentech, Living Tumor Laboratory

What are the Application segmentation covered in the Oncology Based Preclinical CRO Market report?

Ans: The Applications covered in the Oncology Based Preclinical CRO Market report are In Vitro, In Vivo

What are the Type segmentation covered in the Oncology Based Preclinical CRO Market report?

Ans: The Types covered in the Oncology Based Preclinical CRO Market report are Blood Cancer, Solid Tumors, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Based Preclinical CRO Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Blood Cancer
1.2.3 Solid Tumors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncology Based Preclinical CRO Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 In Vitro
1.3.3 In Vivo
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Based Preclinical CRO Market Perspective (2021–2032)
2.2 Global Oncology Based Preclinical CRO Growth Trends by Region
2.2.1 Global Oncology Based Preclinical CRO Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Oncology Based Preclinical CRO Historic Market Size by Region (2021–2026)
2.2.3 Oncology Based Preclinical CRO Forecasted Market Size by Region (2027–2032)
2.3 Oncology Based Preclinical CRO Market Dynamics
2.3.1 Oncology Based Preclinical CRO Industry Trends
2.3.2 Oncology Based Preclinical CRO Market Drivers
2.3.3 Oncology Based Preclinical CRO Market Challenges
2.3.4 Oncology Based Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Based Preclinical CRO Players by Revenue
3.1.1 Global Top Oncology Based Preclinical CRO Players by Revenue (2021–2026)
3.1.2 Global Oncology Based Preclinical CRO Revenue Market Share by Players (2021–2026)
3.2 Global Top Oncology Based Preclinical CRO Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Oncology Based Preclinical CRO Revenue
3.4 Global Oncology Based Preclinical CRO Market Concentration Ratio
3.4.1 Global Oncology Based Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Based Preclinical CRO Revenue in 2025
3.5 Global Key Players of Oncology Based Preclinical CRO Head Offices and Areas Served
3.6 Global Key Players of Oncology Based Preclinical CRO, Products and Applications
3.7 Global Key Players of Oncology Based Preclinical CRO, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Oncology Based Preclinical CRO Breakdown Data by Type
4.1 Global Oncology Based Preclinical CRO Historic Market Size by Type (2021–2026)
4.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Type (2027–2032)
5 Oncology Based Preclinical CRO Breakdown Data by Application
5.1 Global Oncology Based Preclinical CRO Historic Market Size by Application (2021–2026)
5.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Oncology Based Preclinical CRO Market Size (2021–2032)
6.2 North America Oncology Based Preclinical CRO Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Oncology Based Preclinical CRO Market Size by Country (2021–2026)
6.4 North America Oncology Based Preclinical CRO Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Based Preclinical CRO Market Size (2021–2032)
7.2 Europe Oncology Based Preclinical CRO Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Oncology Based Preclinical CRO Market Size by Country (2021–2026)
7.4 Europe Oncology Based Preclinical CRO Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Oncology Based Preclinical CRO Market Size (2021–2032)
8.2 Asia-Pacific Oncology Based Preclinical CRO Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2021–2026)
8.4 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Oncology Based Preclinical CRO Market Size (2021–2032)
9.2 Latin America Oncology Based Preclinical CRO Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Oncology Based Preclinical CRO Market Size by Country (2021–2026)
9.4 Latin America Oncology Based Preclinical CRO Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Based Preclinical CRO Market Size (2021–2032)
10.2 Middle East & Africa Oncology Based Preclinical CRO Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2021–2026)
10.4 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Details
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Oncology Based Preclinical CRO Introduction
11.1.4 Crown Bioscience Revenue in Oncology Based Preclinical CRO Business (2021–2026)
11.1.5 Crown Bioscience Recent Development
11.2 Charles River
11.2.1 Charles River Company Details
11.2.2 Charles River Business Overview
11.2.3 Charles River Oncology Based Preclinical CRO Introduction
11.2.4 Charles River Revenue in Oncology Based Preclinical CRO Business (2021–2026)
11.2.5 Charles River Recent Development
11.3 ICON
11.3.1 ICON Company Details
11.3.2 ICON Business Overview
11.3.3 ICON Oncology Based Preclinical CRO Introduction
11.3.4 ICON Revenue in Oncology Based Preclinical CRO Business (2021–2026)
11.3.5 ICON Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Oncology Based Preclinical CRO Introduction
11.4.4 Eurofins Scientific Revenue in Oncology Based Preclinical CRO Business (2021–2026)
11.4.5 Eurofins Scientific Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Details
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Oncology Based Preclinical CRO Introduction
11.5.4 Taconic Biosciences Revenue in Oncology Based Preclinical CRO Business (2021–2026)
11.5.5 Taconic Biosciences Recent Development
11.6 Covance
11.6.1 Covance Company Details
11.6.2 Covance Business Overview
11.6.3 Covance Oncology Based Preclinical CRO Introduction
11.6.4 Covance Revenue in Oncology Based Preclinical CRO Business (2021–2026)
11.6.5 Covance Recent Development
11.7 EVOTEC
11.7.1 EVOTEC Company Details
11.7.2 EVOTEC Business Overview
11.7.3 EVOTEC Oncology Based Preclinical CRO Introduction
11.7.4 EVOTEC Revenue in Oncology Based Preclinical CRO Business (2021–2026)
11.7.5 EVOTEC Recent Development
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Details
11.8.2 The Jackson Laboratory Business Overview
11.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Introduction
11.8.4 The Jackson Laboratory Revenue in Oncology Based Preclinical CRO Business (2021–2026)
11.8.5 The Jackson Laboratory Recent Development
11.9 MI Bioresearch
11.9.1 MI Bioresearch Company Details
11.9.2 MI Bioresearch Business Overview
11.9.3 MI Bioresearch Oncology Based Preclinical CRO Introduction
11.9.4 MI Bioresearch Revenue in Oncology Based Preclinical CRO Business (2021–2026)
11.9.5 MI Bioresearch Recent Development
11.10 Champion Oncology
11.10.1 Champion Oncology Company Details
11.10.2 Champion Oncology Business Overview
11.10.3 Champion Oncology Oncology Based Preclinical CRO Introduction
11.10.4 Champion Oncology Revenue in Oncology Based Preclinical CRO Business (2021–2026)
11.10.5 Champion Oncology Recent Development
11.11 Wuxi AppTec.
11.11.1 Wuxi AppTec. Company Details
11.11.2 Wuxi AppTec. Business Overview
11.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Introduction
11.11.4 Wuxi AppTec. Revenue in Oncology Based Preclinical CRO Business (2021–2026)
11.11.5 Wuxi AppTec. Recent Development
11.12 Xentech
11.12.1 Xentech Company Details
11.12.2 Xentech Business Overview
11.12.3 Xentech Oncology Based Preclinical CRO Introduction
11.12.4 Xentech Revenue in Oncology Based Preclinical CRO Business (2021–2026)
11.12.5 Xentech Recent Development
11.13 Living Tumor Laboratory
11.13.1 Living Tumor Laboratory Company Details
11.13.2 Living Tumor Laboratory Business Overview
11.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Introduction
11.13.4 Living Tumor Laboratory Revenue in Oncology Based Preclinical CRO Business (2021–2026)
11.13.5 Living Tumor Laboratory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
Evotec AG
The Jackson Laboratory
MI Bioresearch
Champion Oncology
WuXi AppTec
Xentech
Living Tumor Laboratory
List of Tables
 Table 1. Global Oncology Based Preclinical CRO Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Blood Cancer
 Table 3. Key Players of Solid Tumors
 Table 4. Key Players of Others
 Table 5. Global Oncology Based Preclinical CRO Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Oncology Based Preclinical CRO Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Oncology Based Preclinical CRO Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Oncology Based Preclinical CRO Market Share by Region (2021–2026)
 Table 9. Global Oncology Based Preclinical CRO Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Oncology Based Preclinical CRO Market Share by Region (2027–2032)
 Table 11. Oncology Based Preclinical CRO Market Trends
 Table 12. Oncology Based Preclinical CRO Market Drivers
 Table 13. Oncology Based Preclinical CRO Market Challenges
 Table 14. Oncology Based Preclinical CRO Market Restraints
 Table 15. Global Oncology Based Preclinical CRO Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Oncology Based Preclinical CRO Market Share by Players (2021–2026)
 Table 17. Global Top Oncology Based Preclinical CRO Players by Tier (Tier 1, Tier 2, and Tier 3), based on Oncology Based Preclinical CRO Revenue, 2025
 Table 18. Ranking of Global Top Oncology Based Preclinical CRO Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Oncology Based Preclinical CRO Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Oncology Based Preclinical CRO, Headquarters and Area Served
 Table 21. Global Key Players of Oncology Based Preclinical CRO, Products and Applications
 Table 22. Global Key Players of Oncology Based Preclinical CRO, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Oncology Based Preclinical CRO Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Oncology Based Preclinical CRO Revenue Market Share by Type (2021–2026)
 Table 26. Global Oncology Based Preclinical CRO Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Oncology Based Preclinical CRO Revenue Market Share by Type (2027–2032)
 Table 28. Global Oncology Based Preclinical CRO Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Oncology Based Preclinical CRO Revenue Market Share by Application (2021–2026)
 Table 30. Global Oncology Based Preclinical CRO Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Oncology Based Preclinical CRO Revenue Market Share by Application (2027–2032)
 Table 32. North America Oncology Based Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Oncology Based Preclinical CRO Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Oncology Based Preclinical CRO Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Oncology Based Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Oncology Based Preclinical CRO Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Oncology Based Preclinical CRO Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Oncology Based Preclinical CRO Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Oncology Based Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Oncology Based Preclinical CRO Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Oncology Based Preclinical CRO Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Oncology Based Preclinical CRO Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (US$ Million), 2027–2032
 Table 47. Crown Bioscience Company Details
 Table 48. Crown Bioscience Business Overview
 Table 49. Crown Bioscience Oncology Based Preclinical CRO Product
 Table 50. Crown Bioscience Revenue in Oncology Based Preclinical CRO Business (US$ Million), 2021–2026
 Table 51. Crown Bioscience Recent Development
 Table 52. Charles River Company Details
 Table 53. Charles River Business Overview
 Table 54. Charles River Oncology Based Preclinical CRO Product
 Table 55. Charles River Revenue in Oncology Based Preclinical CRO Business (US$ Million), 2021–2026
 Table 56. Charles River Recent Development
 Table 57. ICON Company Details
 Table 58. ICON Business Overview
 Table 59. ICON Oncology Based Preclinical CRO Product
 Table 60. ICON Revenue in Oncology Based Preclinical CRO Business (US$ Million), 2021–2026
 Table 61. ICON Recent Development
 Table 62. Eurofins Scientific Company Details
 Table 63. Eurofins Scientific Business Overview
 Table 64. Eurofins Scientific Oncology Based Preclinical CRO Product
 Table 65. Eurofins Scientific Revenue in Oncology Based Preclinical CRO Business (US$ Million), 2021–2026
 Table 66. Eurofins Scientific Recent Development
 Table 67. Taconic Biosciences Company Details
 Table 68. Taconic Biosciences Business Overview
 Table 69. Taconic Biosciences Oncology Based Preclinical CRO Product
 Table 70. Taconic Biosciences Revenue in Oncology Based Preclinical CRO Business (US$ Million), 2021–2026
 Table 71. Taconic Biosciences Recent Development
 Table 72. Covance Company Details
 Table 73. Covance Business Overview
 Table 74. Covance Oncology Based Preclinical CRO Product
 Table 75. Covance Revenue in Oncology Based Preclinical CRO Business (US$ Million), 2021–2026
 Table 76. Covance Recent Development
 Table 77. EVOTEC Company Details
 Table 78. EVOTEC Business Overview
 Table 79. EVOTEC Oncology Based Preclinical CRO Product
 Table 80. EVOTEC Revenue in Oncology Based Preclinical CRO Business (US$ Million), 2021–2026
 Table 81. EVOTEC Recent Development
 Table 82. The Jackson Laboratory Company Details
 Table 83. The Jackson Laboratory Business Overview
 Table 84. The Jackson Laboratory Oncology Based Preclinical CRO Product
 Table 85. The Jackson Laboratory Revenue in Oncology Based Preclinical CRO Business (US$ Million), 2021–2026
 Table 86. The Jackson Laboratory Recent Development
 Table 87. MI Bioresearch Company Details
 Table 88. MI Bioresearch Business Overview
 Table 89. MI Bioresearch Oncology Based Preclinical CRO Product
 Table 90. MI Bioresearch Revenue in Oncology Based Preclinical CRO Business (US$ Million), 2021–2026
 Table 91. MI Bioresearch Recent Development
 Table 92. Champion Oncology Company Details
 Table 93. Champion Oncology Business Overview
 Table 94. Champion Oncology Oncology Based Preclinical CRO Product
 Table 95. Champion Oncology Revenue in Oncology Based Preclinical CRO Business (US$ Million), 2021–2026
 Table 96. Champion Oncology Recent Development
 Table 97. Wuxi AppTec. Company Details
 Table 98. Wuxi AppTec. Business Overview
 Table 99. Wuxi AppTec. Oncology Based Preclinical CRO Product
 Table 100. Wuxi AppTec. Revenue in Oncology Based Preclinical CRO Business (US$ Million), 2021–2026
 Table 101. Wuxi AppTec. Recent Development
 Table 102. Xentech Company Details
 Table 103. Xentech Business Overview
 Table 104. Xentech Oncology Based Preclinical CRO Product
 Table 105. Xentech Revenue in Oncology Based Preclinical CRO Business (US$ Million), 2021–2026
 Table 106. Xentech Recent Development
 Table 107. Living Tumor Laboratory Company Details
 Table 108. Living Tumor Laboratory Business Overview
 Table 109. Living Tumor Laboratory Oncology Based Preclinical CRO Product
 Table 110. Living Tumor Laboratory Revenue in Oncology Based Preclinical CRO Business (US$ Million), 2021–2026
 Table 111. Living Tumor Laboratory Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Oncology Based Preclinical CRO Picture
 Figure 2. Global Oncology Based Preclinical CRO Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Oncology Based Preclinical CRO Market Share by Type: 2025 vs 2032
 Figure 4. Blood Cancer Features
 Figure 5. Solid Tumors Features
 Figure 6. Others Features
 Figure 7. Global Oncology Based Preclinical CRO Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Oncology Based Preclinical CRO Market Share by Application: 2025 vs 2032
 Figure 9. In Vitro Case Studies
 Figure 10. In Vivo Case Studies
 Figure 11. Oncology Based Preclinical CRO Report Years Considered
 Figure 12. Global Oncology Based Preclinical CRO Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Oncology Based Preclinical CRO Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Oncology Based Preclinical CRO Market Share by Region: 2025 vs 2032
 Figure 15. Global Oncology Based Preclinical CRO Market Share by Players in 2025
 Figure 16. Global Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Oncology Based Preclinical CRO Revenue in 2025
 Figure 18. North America Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Oncology Based Preclinical CRO Market Share by Country (2021–2032)
 Figure 20. United States Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Oncology Based Preclinical CRO Market Share by Country (2021–2032)
 Figure 24. Germany Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Oncology Based Preclinical CRO Market Share by Region (2021–2032)
 Figure 32. China Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Oncology Based Preclinical CRO Market Share by Country (2021–2032)
 Figure 40. Mexico Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Oncology Based Preclinical CRO Market Share by Country (2021–2032)
 Figure 44. Israel Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Oncology Based Preclinical CRO Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Crown Bioscience Revenue Growth Rate in Oncology Based Preclinical CRO Business (2021–2026)
 Figure 48. Charles River Revenue Growth Rate in Oncology Based Preclinical CRO Business (2021–2026)
 Figure 49. ICON Revenue Growth Rate in Oncology Based Preclinical CRO Business (2021–2026)
 Figure 50. Eurofins Scientific Revenue Growth Rate in Oncology Based Preclinical CRO Business (2021–2026)
 Figure 51. Taconic Biosciences Revenue Growth Rate in Oncology Based Preclinical CRO Business (2021–2026)
 Figure 52. Covance Revenue Growth Rate in Oncology Based Preclinical CRO Business (2021–2026)
 Figure 53. EVOTEC Revenue Growth Rate in Oncology Based Preclinical CRO Business (2021–2026)
 Figure 54. The Jackson Laboratory Revenue Growth Rate in Oncology Based Preclinical CRO Business (2021–2026)
 Figure 55. MI Bioresearch Revenue Growth Rate in Oncology Based Preclinical CRO Business (2021–2026)
 Figure 56. Champion Oncology Revenue Growth Rate in Oncology Based Preclinical CRO Business (2021–2026)
 Figure 57. Wuxi AppTec. Revenue Growth Rate in Oncology Based Preclinical CRO Business (2021–2026)
 Figure 58. Xentech Revenue Growth Rate in Oncology Based Preclinical CRO Business (2021–2026)
 Figure 59. Living Tumor Laboratory Revenue Growth Rate in Oncology Based Preclinical CRO Business (2021–2026)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Preclinical Oncology CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Based In vitro CRO Market Research Report 2024
Global Oncology Based In vivo CRO Market Research Report 2024
Global Preclinical Contract Research Organization CRO Market Research Report 2025
Global Pharmaceutical Development Preclinical CRO Market Research Report 2025
Clinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Preclinical CRO Treatment Market Insights Forecast to 2030
Global Pre Clinical CROs Services Market Research Report 2024
Pre Clinical Contract Research Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contract Research Organisations CROs Market Research Report 2024
Global Full Service CRO Market Research Report 2024
Global Healthcare Contract Research Organization Market Insights Forecast to 2030
Global CRO in Clinical Trials Market Research Report 2024
Global Full Service Clinical Research Organization CRO Market Research Report 2025
Clinical Research Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Clinical Contract Research Organization Services Market Research Report 2024
Global Clinical and Non clinical Contract Research Organization Services Market Research Report 2024
Healthcare Contract Research Organizations CRO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contract Research Organization Solution Market Research Report 2025
Contract Research Organizations Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions